News
NVAX
3.970
+2.06%
0.080
What's in Store for Biogen (BIIB) This Earnings Season?
NASDAQ · 21h ago
NOVAVAX TO SUPPLY UPDATED COVID-19 VACCINE TO PRIVATE HEALTHCARE PROVIDERS IN THE UNITED KINGDOM
Reuters · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Snap One, Encore Wire, Centene
The Dow Jones Industrial Average was down 0.45% on Monday. Goldman Sachs boosted by robust gains. Snap One, Encore Wire, Centene were among the top stocks on the NYSE. The S&P 500 and Nasdaq Composite both fell on the day. U.S. Retail sales were stronger than expected.
Reuters · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-Cisco Systems, Inspired Entertainment, Spirit Airlines
Dow Jones Industrial Average was up 0.36% at 38,119.77. Goldman Sachs boosted by robust gains. Top three S&P 500 percentage gainers: M&T Bank, Centene, Snap One. Apple down 0.6% after falling in premarket trading.
Reuters · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-Encore Wire, Masimo, Goldman Sachs
Wall Street's main stock indexes eyed a higher open on Monday. Dow e-minis up 0.82%, S&P 500 and Nasdaq 100 also up. Goldman Sachs, Encore Wire, Masimo, Lockheed Martin among top stocks on the move. Tensions in the Middle East make investors wary of the U.S.
Reuters · 4d ago
What's Going On With Novavax Stock Today?
Shah Capital Management reported a 6.66% stake in Novavax Inc. The hedge fund has nominated two new directors for the company's board. Shah Capital says it is disappointed with the recent performance of the company. The company's shares are trading higher Monday.
Benzinga · 4d ago
Shah Capital calls for board shake-up at Novavax
Healthcare Shah Capital calls for board shake-up at Novavax. The hedge fund is a top-five shareholder in the company. The fund identifies ongoing operating losses, marketing failures, and questionable regulatory management among issues plaguing the firm. Shah Capital has nominated two independent director candidates for the board.
Seeking Alpha · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-Longeveron, Novavax, Telsa
U.S. Stock index futures rise on Monday. Dow and S&P 500 e-minis up 0.47% and 0.55% respectively. Longeveron, Novavax, Telsa among top Nasdaq percentage gainers. Wall Street suffered a bruising sell-off in the previous session.
Reuters · 4d ago
FACTBOX-US, Canadian companies kick off 2024 with layoffs
Companies in the United States and Canada have kicked off 2024 with thousands of job cuts across sectors. Amazon, Microsoft, eBay and others have announced job cuts in the first week of the year. Layoffs come as companies scramble to rein in costs in the face of a slowing economy.
Reuters · 4d ago
Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says
MarketWatch · 5d ago
BUZZ-Novavax rises after hedge fund Shah Capital recommends two new director candidates
U.S.-based hedge fund Shah Capital recommends appointment of two independent directors to Novavax board. Shares of vaccine maker rise 3.5% to $4.43 premarket. Shah Capital says low share price reflects failure to capitalize on company's competitive advantages.
Reuters · 5d ago
NOVAVAX SHARES UP 3.3% PREMARKET AFTER US HEDGE FUND SHAH CAPITAL RECOMMENDS TWO NEW DIRECTOR CANDIDATES
Reuters · 5d ago
SHAH CAPITAL NOMINATES TWO HIGHLY QUALIFIED INDEPENDENT DIRECTOR CANDIDATES FOR NOVAVAX
Reuters · 5d ago
SHAH CAPITAL SAYS NOMINATES SURESH KATTA & VENKAT PERI TO NOVAVAX BOARD
Reuters · 5d ago
Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push
TipRanks · 5d ago
Weekly Report: what happened at NVAX last week (0408-0412)?
Weekly Report · 5d ago
UPDATE 5-Novavax investor Shah Capital pushes for board shakeup
Novavax investor Shah Capital pushes for board shakeup of vaccine maker. Shah Capital owns a 6.7% stake in Novavax. The hedge fund says the company has been badly mismanaged. The company's shares fell 3.5% to $4.13 on Monday.
Reuters · 5d ago
Hedge fund Shah Capital urges board shake-up at Novavax over struggling Covid vaccine, FT reports
Hedge fund Shah Capital urges board shake-up at Novavax over struggling Covid vaccine, FT reports. U.S.-based hedge fund wants two independent board directors for the biotech company. Shah Capital also wants a pivot in the sales strategy for its Covid-19 shot.
Reuters · 5d ago
US-BASED HEDGE FUND SHAH CAPITAL WROTE TO THE NOVAVAX BOARD ON MONDAY TO PUSH FOR THE INSTALMENT OF TWO NEW INDEPENDENT BOARD DIRECTORS- FT
Reuters · 5d ago
HEDGE FUND URGES BOARD SHAKE-UP AT NOVAVAX OVER STRUGGLING COVID VACCINE - FT
Reuters · 5d ago
More
Webull provides a variety of real-time NVAX stock news. You can receive the latest news about Novavax Inc through multiple platforms. This information may help you make smarter investment decisions.
About NVAX
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.